Skip to main content

Table 1 Total and linear distances travelled by fMLP-stimulated neutrophils collected from individuals before and after 2-weeks of placebo or GSP supplementation. Values are expressed as means and standard deviations (SD)

From: Anti-inflammatory cellular targets on neutrophils elucidated using a novel cell migration model and confocal microscopy: a clinical supplementation study

Neutrophil chemokinetic indicators PLACEBO GSP
Unstimulated Stimulated Unstimulated Stimulated
PRE POST PRE POST PRE POST PRE POST
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Total Distance (um) 65.08 (37.30) 73.26 (35.46) 83.32* (54.66) 143.21* (60.77) 92.64 (56.14) 81.24 (43.68) 112.90* (69.78) 155.78* (67.11)
Linear distance (um) 12.67 (13.93) 16.61 (10.470 26.66a (16.57) 53.19 (29.16)* 13.54 (10.71) 13.52 (42.91) 35.30a (25.27) 42.91* (29.01)
  1. Statistical analysis: ANOVA and post hoc Fischer’s LSD test, (n = 9 per group)
  2. *P < 0.05 at least, effect of stimulation; aeffect of stimulation, P = 0.06
  3. No effect of time or treatment